Related Experiment Videos
Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides
Christopher Kirsch1, Gunter P Eckert, Walter E Mueller
1Department of Pharmacology, Biocenter Niederursel, University of Frankfurt, Germany.
Abstract:
Growing evidence indicates a significant linkage between Abeta and cholesterol metabolism, although the exact role of cholesterol in brain aging and in the pathogenesis of AD is still unknown. Recently, in vitro and in vivo modification of cell cholesterol and its effect on Abeta-generation became a straight focus in the research of AD. In the present study, we discretely modulated the cholesterol contents of neuronal membranes from mice of different ages in vivo and in vitro using lovastatin and methyl-beta-cyclodextrin, respectively. The aim of the study was to investigate whether this modulation results in altered physico-chemical membrane properties. Therefore, we performed membrane fluidity measurements using three fluorescent dyes labeling different membrane regions. Furthermore, we evaluated the effects of cholesterol modulation on the membrane disturbing properties of Abeta. Modulation of membrane cholesterol content in vivo and in vitro was linked to changes in membrane properties. Very interestingly, cholesterol content of in vitro modulated neuronal membranes was negatively correlated with the membrane perturbing effects of Abeta.
Insights
Altering brain cell cholesterol levels impacts membrane properties and amyloid-beta (Abeta) interactions. Lowering cholesterol in neuronal membranes reduced Abeta
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Growing evidence links amyloid-beta (Abeta) and cholesterol metabolism in Alzheimer's disease (AD).
- The precise role of cholesterol in brain aging and AD pathogenesis remains unclear.
- Investigating cholesterol's effect on Abeta generation is a key research focus in AD.
Purpose of the Study:
- To investigate how modulating neuronal membrane cholesterol affects physico-chemical membrane properties.
- To evaluate the impact of altered cholesterol levels on the membrane-disturbing effects of Abeta.
Main Methods:
- In vivo and in vitro modulation of mouse neuronal membrane cholesterol using lovastatin and methyl-beta-cyclodextrin.
- Measurement of membrane fluidity using three fluorescent dyes targeting different membrane regions.
- Assessment of Abeta's membrane-disturbing properties following cholesterol modulation.
Main Results:
- Cholesterol modulation, both in vivo and in vitro, altered neuronal membrane properties.
- A significant negative correlation was observed between cholesterol content and Abeta's membrane-perturbing effects in vitro.
- Changes in membrane fluidity were detected following cholesterol level adjustments.
Conclusions:
- Neuronal membrane cholesterol content influences membrane physical properties.
- Modulating cholesterol levels affects how Abeta interacts with and disturbs neuronal membranes.
- Findings suggest a potential therapeutic target for AD by managing cholesterol in brain cells.